Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	147.62M
Revenue (ttm)	89.88M
Net Income (ttm)	16.93M
Shares Out	581.33M
EPS (ttm)	0.03
PE Ratio	9.66
Forward PE	7.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,532
Average Volume	212,956
Open	0.3600
Previous Close	0.3600
Day's Range	0.3315 - 0.3500
52-Week Range	0.2750 - 0.5400
Beta	0.23
RSI	43.35
Earnings Date	May 30, 2025

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP